Skip to main content

BlackRock, Inc.

Position in MRK — Merck & Co., Inc.

CIK 2012383 New York, NY

Position in MRK

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$27,165,130,383
+$4,103,141,749 QoQ
Shares Held
225,830,330
+3.1% QoQ
Ownership
9.14%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority Sole 91.00506384594134.ToString("F0")% Shared 0.ToString("F0")% None 8.994936154058669.ToString("F0")%

Common Shares in MRK Over Time

Shares Held

Position Value (USD)

Derivatives in MRK

reported options exposure · as of Mar 31, 2026
CallValue
$11,547,840
CallShares
96,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

BlackRock, Inc. holds $235,197,977,777 across 20 Drug Manufacturers - General names. MRK ranks #4 (11.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 MRK
Merck & Co., Inc.
This page
225,830,330 $27,165,130,383

All Filings in MRK

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $11,547,840 96,000
2026-03-31 $27,165,130,383 225,830,330
2025-12-31 $23,061,988,634 219,095,465
2025-09-30 $18,034,593,026 214,876,600
2025-06-30 $17,283,860,254 218,340,832
2025-03-31 $20,231,745,202 225,398,231
2024-12-31 $22,092,701,931 222,081,845
2024-09-30 $24,081,503,721 212,059,737
2024-09-30 $104,815,880 923,000